Page last updated: 2024-11-05

tremorine and Parkinson Disease, Postencephalitic

tremorine has been researched along with Parkinson Disease, Postencephalitic in 1 studies

Parkinson Disease, Postencephalitic: Parkinsonism following encephalitis, historically seen as a sequella of encephalitis lethargica (Von Economo Encephalitis). The early age of onset, the rapid progression of symptoms followed by stabilization, and the presence of a variety of other neurological disorders (e.g., sociopathic behavior; TICS; MUSCLE SPASMS; oculogyric crises; hyperphagia; and bizarre movements) distinguish this condition from primary PARKINSON DISEASE. Pathologic features include neuronal loss and gliosis concentrated in the MESENCEPHALON; SUBTHALAMUS; and HYPOTHALAMUS. (From Adams et al., Principles of Neurology, 6th ed, p754)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mattila, MJ1
Spiers, AS1
Sharkey, J1
Laurence, DR1

Trials

1 trial available for tremorine and Parkinson Disease, Postencephalitic

ArticleYear
Dissociation of antitremorine activity and clinical antiparkinsonian effect. A clinical trial of AGN 511 in postencephalitic parkinsonism.
    Arzneimittel-Forschung, 1970, Volume: 20, Issue:12

    Topics: Animals; Barbiturates; Humans; Mice; Parasympatholytics; Parkinson Disease, Postencephalitic; Piperi

1970